Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination

View ORCID ProfileRishi R. Goel, Sokratis A. Apostolidis, Mark M. Painter, Divij Mathew, Ajinkya Pattekar, Oliva Kuthuru, Sigrid Gouma, Leticia Kuri-Cervantes, Wenzhao Meng, Sharon Adamski, Amy E. Baxter, Josephine R. Giles, Madison E. Weirick, Christopher M. McAllister, Amanda Hicks, Scott Korte, Jeanette Dougherty, Sherea Long, Kurt D’Andrea, Jacob T. Hamilton, Eline T Luning Prak, Michael R. Betts, Paul Bates, Scott E. Hensley, Allison R. Greenplate, View ORCID ProfileE. John Wherry
doi: https://doi.org/10.1101/2021.03.03.21252872
Rishi R. Goel
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rishi R. Goel
Sokratis A. Apostolidis
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
3Division of Rheumatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark M. Painter
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Divij Mathew
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ajinkya Pattekar
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliva Kuthuru
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sigrid Gouma
4Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leticia Kuri-Cervantes
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
4Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenzhao Meng
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
5Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon Adamski
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy E. Baxter
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josephine R. Giles
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
6Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
7Parker Institute for Cancer Immunotherapy, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madison E. Weirick
4Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M. McAllister
4Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Hicks
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott Korte
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanette Dougherty
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sherea Long
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt D’Andrea
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob T. Hamilton
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eline T Luning Prak
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
5Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael R. Betts
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
4Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Bates
4Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott E. Hensley
4Department of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allison R. Greenplate
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. John Wherry
1Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
2Immune Health™, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
6Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
7Parker Institute for Cancer Immunotherapy, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E. John Wherry
  • For correspondence: wherry@pennmedicine.upenn.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Novel mRNA vaccines for SARS-CoV2 have been authorized for emergency use and are currently being administered to millions of individuals worldwide. Despite their efficacy in clinical trials, there is limited data on vaccine-induced immune responses in individuals with a prior SARS-CoV2 infection compared to SARS-CoV2 naïve subjects. Moreover, how mRNA vaccines impact the development of antibodies as well as memory B cells in COVID-19 experienced versus COVID-19 naïve subjects remains poorly understood. In this study, we evaluated antibody responses and antigen-specific memory B cell responses over time in 33 SARS-CoV2 naïve and 11 SARS-CoV2 recovered subjects. mRNA vaccination induced significant antibody and memory B cell responses against full-length SARS-CoV2 spike protein and the spike receptor binding domain (RBD). SARS-CoV2 naïve individuals benefitted from both doses of mRNA vaccine with additional increases in antibodies and memory B cells following booster immunization. In contrast, SARS-CoV2 recovered individuals had a significant immune response after the first dose with no increase in circulating antibodies or antigen-specific memory B cells after the second dose. Moreover, the magnitude of the memory B cell response induced by vaccination was lower in older individuals, revealing an age-dependence to mRNA vaccine-induced B cell memory. Side effects also tended to associate with post-boost antibody levels, but not with post-boost memory B cells, suggesting that side effect severity may be a surrogate of short-term antibody responses. The frequency of pre-vaccine antigen-specific memory B cells in SARS-CoV2 recovered individuals strongly correlated with post-vaccine antibody levels, supporting a key role for memory B cells in humoral recall responses to SARS-CoV2. This observation may have relevance for future booster vaccines and for responses to viral variants that partially escape pre-existing antibodies and require new humoral responses to be generated from memory B cells. Finally, post-boost antibody levels were not correlated with post-boost memory responses in SARS-CoV2 naïve individuals, indicating that short-term antibody levels and memory B cells are complementary immunological endpoints that should be examined in tandem when evaluating vaccine response. Together, our data provide evidence of both serological response and immunological memory following mRNA vaccination that is distinct based on prior SARS-CoV2 exposure. These findings may inform vaccine distribution in a resource-limited setting.

Figure
  • Download figure
  • Open in new tab

Competing Interest Statement

EJW is consulting or is an advisor for Merck, Elstar, Janssen, Related Sciences, Synthekine and Surface Oncology. EJW is a founder of Surface Oncology and Arsenal Biosciences. EJW is an inventor on a patent (US Patent number 10,370,446) submitted by Emory University that covers the use of PD-1 blockade to treat infections and cancer.

Funding Statement

This work was supported by grants from NIH: AI105343 and AI082630 (EJW); T32 AR076951-01 (SAA); HL143613, and T32 CA009140 (JRG). This work was also supported by the University of Pennsylvania Perelman School of Medicine COVID fund; the Allen Institute for Immunology (SAA, EJW); the Chen Family Research Fund (SAA); and a Cancer Research Institute-Mark Foundation Fellowship (JRG). RRG was supported through a Raffensperger 21st Century Scholar Award from the University of Pennsylvania. JRG and EJW are also funded by the Parker Institute for Cancer Immunotherapy which supports the Cancer Immunology Program at the University of Pennsylvania. We further thank Jeffrey Lurie and Joel Embiid, Josh Harris, and David Blitzer for philanthropic support.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

44 individuals (33 SARS-CoV2 naive, 11 SARS-CoV2 recovered) were consented and enrolled in the study with approval from the University of Pennsylvania Institutional Review Board (IRB# 844642).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data is available from the authors upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 06, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination
Rishi R. Goel, Sokratis A. Apostolidis, Mark M. Painter, Divij Mathew, Ajinkya Pattekar, Oliva Kuthuru, Sigrid Gouma, Leticia Kuri-Cervantes, Wenzhao Meng, Sharon Adamski, Amy E. Baxter, Josephine R. Giles, Madison E. Weirick, Christopher M. McAllister, Amanda Hicks, Scott Korte, Jeanette Dougherty, Sherea Long, Kurt D’Andrea, Jacob T. Hamilton, Eline T Luning Prak, Michael R. Betts, Paul Bates, Scott E. Hensley, Allison R. Greenplate, E. John Wherry
medRxiv 2021.03.03.21252872; doi: https://doi.org/10.1101/2021.03.03.21252872
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA Vaccination
Rishi R. Goel, Sokratis A. Apostolidis, Mark M. Painter, Divij Mathew, Ajinkya Pattekar, Oliva Kuthuru, Sigrid Gouma, Leticia Kuri-Cervantes, Wenzhao Meng, Sharon Adamski, Amy E. Baxter, Josephine R. Giles, Madison E. Weirick, Christopher M. McAllister, Amanda Hicks, Scott Korte, Jeanette Dougherty, Sherea Long, Kurt D’Andrea, Jacob T. Hamilton, Eline T Luning Prak, Michael R. Betts, Paul Bates, Scott E. Hensley, Allison R. Greenplate, E. John Wherry
medRxiv 2021.03.03.21252872; doi: https://doi.org/10.1101/2021.03.03.21252872

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (270)
  • Allergy and Immunology (552)
  • Anesthesia (135)
  • Cardiovascular Medicine (1757)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (658)
  • Epidemiology (10796)
  • Forensic Medicine (8)
  • Gastroenterology (589)
  • Genetic and Genomic Medicine (2946)
  • Geriatric Medicine (287)
  • Health Economics (534)
  • Health Informatics (1927)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (291)
  • HIV/AIDS (630)
  • Infectious Diseases (except HIV/AIDS) (12515)
  • Intensive Care and Critical Care Medicine (688)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2798)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1463)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (866)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (337)
  • Psychiatry and Clinical Psychology (2639)
  • Public and Global Health (5363)
  • Radiology and Imaging (1011)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (125)